22.00
Progyny Inc stock is traded at $22.00, with a volume of 1.28M.
It is down -4.39% in the last 24 hours and up +1.62% over the past month.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
See More
Previous Close:
$23.01
Open:
$23.1
24h Volume:
1.28M
Relative Volume:
1.18
Market Cap:
$1.89B
Revenue:
$1.13B
Net Income/Loss:
$62.75M
P/E Ratio:
34.92
EPS:
0.63
Net Cash Flow:
$170.92M
1W Performance:
-5.21%
1M Performance:
+1.62%
6M Performance:
+4.76%
1Y Performance:
-21.48%
Progyny Inc Stock (PGNY) Company Profile
Name
Progyny Inc
Sector
Industry
Phone
212-888-3124
Address
1359 BROADWAY, NEW YORK, NY
Compare PGNY with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
PGNY
Progyny Inc
|
22.00 | 1.99B | 1.13B | 62.75M | 170.92M | 0.63 |
![]()
UNH
Unitedhealth Group Inc
|
282.65 | 275.86B | 410.06B | 22.11B | 24.86B | 23.88 |
![]()
CI
Cigna Group
|
295.71 | 81.02B | 254.47B | 5.03B | 6.01B | 18.06 |
![]()
CVS
Cvs Health Corp
|
61.96 | 81.95B | 378.96B | 5.28B | 5.94B | 4.19 |
![]()
ELV
Elevance Health Inc
|
277.09 | 76.97B | 189.25B | 5.36B | 5.34B | 23.50 |
![]()
HUM
Humana Inc
|
220.41 | 27.84B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jul-08-25 | Upgrade | Leerink Partners | Market Perform → Outperform |
Dec-02-24 | Downgrade | JP Morgan | Overweight → Neutral |
Nov-13-24 | Downgrade | Truist | Buy → Hold |
Sep-19-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
Aug-07-24 | Downgrade | BTIG Research | Buy → Neutral |
Aug-07-24 | Downgrade | Canaccord Genuity | Buy → Hold |
Aug-07-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
Jul-16-24 | Initiated | JMP Securities | Mkt Outperform |
May-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Feb-26-24 | Initiated | Leerink Partners | Outperform |
Jan-03-24 | Initiated | Barclays | Overweight |
Sep-27-23 | Initiated | Canaccord Genuity | Buy |
May-22-23 | Initiated | BTIG Research | Buy |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jan-05-23 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
Sep-07-22 | Initiated | Truist | Buy |
Dec-02-21 | Initiated | Jefferies | Buy |
Nov-22-21 | Downgrade | Citigroup | Buy → Neutral |
Sep-30-21 | Initiated | Berenberg | Buy |
Aug-12-21 | Initiated | Barclays | Overweight |
Jun-02-21 | Downgrade | Guggenheim | Buy → Neutral |
Apr-29-21 | Resumed | JP Morgan | Overweight |
Mar-10-21 | Upgrade | BofA Securities | Neutral → Buy |
Jul-01-20 | Initiated | SVB Leerink | Outperform |
Jun-02-20 | Initiated | Guggenheim | Buy |
Nov-19-19 | Initiated | Citigroup | Buy |
Nov-19-19 | Initiated | Goldman | Buy |
Nov-19-19 | Initiated | JP Morgan | Overweight |
Nov-19-19 | Initiated | Piper Jaffray | Overweight |
Nov-19-19 | Initiated | SVB Leerink | Outperform |
View All
Progyny Inc Stock (PGNY) Latest News
Progyny Inc. Stock Analysis and ForecastTriple returns potential - Jammu Links News
What drives Progyny Inc. stock priceDynamic investment growth - Jammu Links News
Is Progyny Inc. a good long term investmentHigh-velocity capital appreciation - Jammu Links News
What analysts say about Progyny Inc. stockSuperior profit margins - Jammu Links News
Why Progyny (PGNY) Stock Is Falling Today - Yahoo Finance
Truist Securities Maintains Hold Rating on Progyny (PGNY), Raise - GuruFocus
Progyny (PGNY) Price Target Increased Amid Mixed Investor Sentim - GuruFocus
Progyny partners with Oura for women’s health monitoring By Investing.com - Investing.com Nigeria
Where are the Opportunities in (PGNY) - news.stocktradersdaily.com
Progyny Secures $200M Credit Facility with JPMorgan - TipRanks
Progyny rises on guidance update - MSN
Progyny and Oura: A Wearable Tech Revolution in Women's Health and Its Implications for Investors - AInvest
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitori - GuruFocus
Progyny (PGNY) Partners with OURA to Enhance Healthcare Monitoring | PGNY Stock News - GuruFocus
Progyny partners with Oura for women’s health monitoring - Investing.com Australia
Progyny Partners with ?URA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause | PGNY Stock News - GuruFocus
Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause - The Manila Times
Progyny, Inc. Partners with ŌURA to Enhance Women's Health Insights Through Wearable Technology - Quiver Quantitative
Progyny Partners with ŌURA to Empower Women and Their Care - GlobeNewswire
Truist Financial Keeps Their Hold Rating on Progyny (PGNY) - The Globe and Mail
Progyny (PGNY) Receives a Hold from Canaccord Genuity - The Globe and Mail
BTIG Keeps Their Buy Rating on Progyny (PGNY) - The Globe and Mail
Progyny upgraded to Outperform at Leerink after positive pre-announcement - MSN
Progyny Inc Stock (PGNY): Strong Growth Post Q1 Results - Value The Markets
Strength Seen in Progyny (PGNY): Can Its 13.2% Jump Turn into More Strength? - Yahoo Finance
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance By Investing.com - Investing.com South Africa
Progyny secures $200 million revolving credit facility, expects Q2 results above guidance - Investing.com Nigeria
Leerink Partners upgrades Progyny stock rating to Outperform on improved membership activity - Investing.com Canada
Progyny (PGNY) Receives Rating Upgrade from Leerink Partners | P - GuruFocus
Sector Update: Health Care - MarketScreener
Progyny stock rises as BofA reiterates Buy rating on better-than-expected Q2 - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook - Investing.com Canada
Progyny stock gains as BTIG reiterates Buy rating on favorable Q2 outlook By Investing.com - Investing.com South Africa
Progyny (PGNY) Expects to Surpass Q2 2025 Projections - GuruFocus
Progyny expects Q2 results above previous forecast; shares gain - TradingView
Under the Radar: Hunting Smart in the Alleyway of Value and Growth - Benzinga
Progyny stock (PGNY) rises: what’s going on with Progyny Inc? - Markets.com
Progyny Expects Q2 Results 'Slightly Above' Guidance, Enters $200 Million Revolver; Shares Rise - MarketScreener
Progyny stock rises on guidance update (PGNY:NASDAQ) - Seeking Alpha
Progyny Reveals $200 Mln Revolving Credit Facility, Sees Q2 Results Slightly Ahead Of Expectations - Nasdaq
Progyny, Inc. Enters into A Revolving Credit Facility - MarketScreener
Progyny, Inc. Provides Business Update and Announces Details for - GuruFocus
Progyny, Inc. Secures $200 Million Credit Facility to Enhance Financial Flexibility and Anticipates Positive Second Quarter Results - Nasdaq
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report | PGNY Stock News - GuruFocus
Progyny, Inc. Provides Business Update and Announces Details for Its Second Quarter 2025 Results Report - The Manila Times
(PGNY) Proactive Strategies - news.stocktradersdaily.com
Progyny’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Here’s Why Progyny (PGNY) Rebounded in Q1 - Insider Monkey
Hinge Health joins Progyny for pelvic floor therapy - MSN
Progyny (PGNY) Expands Women's Health Benefits with New Partners - GuruFocus
Progyny Expands Women's Health Offerings with New Pelvic Floor Therapy Services - Nasdaq
Progyny Inc Stock (PGNY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):